Schedule 13G ownership disclosure

INOZYME PHARMA INC

Security class unavailable · CUSIP: 45790W108

Event date: 2024-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,972,318
Percent of class
6.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001839882-24-044356
Form type
SC 13G
Filer
Affinity Asset Advisors, LLC
CIK
CIK 1773195
Filed
Dec 09, 2024
Reporting period
Dec 02, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub